MIS ICH

Thank you to all who participated in the Minimally Invasive Surgery Intracerebral Hemorrhage Consensus Conference held in Baltimore, Maryland at Johns Hopkins University on July 26, 2025.

The MIS ICH Consensus Conference convened a wide-ranging and comprehensive group of field-leading experts as well as the stroke community at large to define the specific discoveries needed to produce level one evidence regarding the possible value of MIS.

Our internationally recognized key opinion leaders and trialists across the full spectrum of current and past pivotal ICH trials facilitated discussion with the goal of defining what is needed to promote practice change in utilizing MIS for ICH patients.

Conference leaders are currently drafting a white paper summarizing the key discussions and consensus points from the conference, and we look forward to sharing the publication with all attendees once it is finalized.


Program Agenda and Speakers

Registration & Continental Breakfast 7 a.m.
WelcomeAndrew Mould & Nichol McBee
Session 1: Unanswered Questions in Intracerebral Hemorrhage
State of ICH Care & Presurgical Pathway​Paul Vespa
Intracerebral Hemorrhage: Public Health BurdenFarhaan Vahidy
Polling
Trial Endpoints & Subgroup PrioritiesDan Hanley
Panel Discussion and Q&AModerator: Farhaan Vahidy
Session 2: Standardizing Surgical Deliverables for Differing Surgical Techniques 
Tools & Techniques for Minimally Invasive Evacuation of ICH​Geoff Colby
MINDBabak Jahromi
Standardizing the Surgical Task in ICH Evacuation TrialsMark Harrigan
Minimally Invasive Surgery and Realtime ImagingSean Polster
Panel Discussion and Q&AModerator: Mark Harrigan

Break

Session 3: Standardizing Pre- and Post- Op Care
Standardizing the ICH Presurgical PathwayPaul Vespa
Optimal Prevention of Thrombosis after Intracerebral hemorrhage with intensive Medical therapy and Antiplatelet medications (OPTIMA)Santosh Murthy
Follow-up Care – REASSESSWendy Ziai
Panel Discussion and Q&AModerator: Wendy Ziai

Lunch will be served just outside the auditorium

Session 4: Answering Biological Questions
Using MIS to Understand Inflammation in the Brain: A Focus on MacrophagesLauren Sansing
Neuroprotection – SGL2Jarek Aronowski
Mechanistic Biomarkers of ICH: Causes and EffectsIssam Awad
Panel Discussion and Q&A Moderator: Lauren Sansing
Session 5: Funding Perspective MIS Trials Design
NIH National Institute of Neurological Disorders and Stroke/StrokeNetScott Janis
PCORI OverviewGodfrey Woelk
Panel Discussion and Q&AModerator: Issam Awad

Break

Session 6: Knowledge Gaps From Prior Trials: 10 Result and 10 Knowledge Gap
Rapid Evacuation and Access of Cerebral Hemorrhage TrialAlex Hall & Jonathan Ratcliff
Early ICH Treatment – MINUTEChris Kellner
Lessons From the FASTEST Trial​Joseph Broderick
Minimally Invasive Surgery for Intracerebral Hemorrhage (MIS ICH)Dan Hanley
Knowledge Gap Panel Discussion and Q&AModerator: Sean Polster
Consensus VotingModerators: Wendy Ziai, Issam Awad, Sean Polster
Closing RemarksWendy Ziai
Adjourn5:30 p.m.


Contact Information